Understanding New Jersey’s Schedule II Medication Rules: What You Need to Know
- jillian9865
- Mar 31
- 4 min read
Updated to include new regulations as of July 8, 2026
If you’ve been prescribed a Schedule II medication (such as certain ADHD medications), you may have noticed changes to how appointments are scheduled—especially around in-person visits.
We know this has been confusing. There’s been shifting guidance, and we want to clearly explain what’s changed, what it means for you, and how we’ve been handling it on our end.
What is a Schedule II Medication?
Schedule II medications are a category of controlled substances that are closely regulated because they have a higher potential for misuse. At the same time, they’re commonly prescribed and highly effective for certain conditions—like ADHD or severe pain—which is why they’re widely used in treatment.
Because of that balance (effective but more tightly controlled), there are stricter rules around how these medications are prescribed and monitored.
What Happened?
During COVID-19, there were temporary rules that allowed providers to prescribe Schedule II medications through telehealth without requiring an in-person visit. In New Jersey, those rules officially ended with Executive Order 415, which went into effect on February 16, 2026.
Once that happened, providers could no longer rely on those emergency flexibilities, meaning that now all new clients being prescribed Schedule II medications need to be seen in person for their first visit and again every 3 months thereafter. If the client is not seen in person within that time frame, the medication can't be refilled.
And then ...New Jersey lawmakers recognized that the new requirements created unnecessary barriers for many patients receiving ongoing treatment—particularly for adults with ADHD who had been safely receiving treatment through telehealth.
In response, Senate Bill S4194 (combined with S4210) was signed into law on July 8, 2026. The new law restores much of the flexibility that patients and providers had been hoping for while still maintaining appropriate safeguards for prescribing Schedule II medications...
What Changed?
For adults prescribed stimulant Schedule II medications for ADHD:
Your initial evaluation must still be completed in person.
At TheraCorp, if your initial evaluation is completed via telehealth, and a Schedule II medication is recommended, we'll get you scheduled for an in-person follow up within 30 days, and at that point, we'll send in your Schedule II prescription.
After that, you may continue with either telehealth or in-person follow-up appointments.
Most mental health practitioners require that all patients who are taking any psychotropic medications see their prescribers once every 3 months for at least the first year of treatment. However, per New Jersey law, individuals being prescribed Schedule II medications must be seen at least once every 6 months (in person or via telehealth).
What This Means for Our Patients
This is welcome news. The new law allows much more flexibility while still ensuring that providers can safely monitor medications that require additional oversight.
For most patients taking stimulant medications for ADHD, this means:
Fewer required trips to the office.
The ability to complete most routine medication follow-ups virtually.
We'll continue to follow all New Jersey and federal regulations and will let you know if your treatment plan requires an in-person appointment. If you ever have questions about whether your next visit can be virtual or needs to be in person, our team is happy to help.
PS - Several clients have asked us if this is unique to TheraCorp. It is not.
What is Unique To TheraCorp?
What we did ahead of time: In anticipation and preparation for this change, starting in October 2025, our team began reaching out to clients to start transitioning to in-person visits early. The goal was to avoid last-minute issues—like finding out too late that you couldn’t make it to an office, or we didn’t have availability to see you in time to continue your medication. By starting early, we were able to spread out scheduling and avoid a bottleneck right before the deadline.
Monthly visits to avoid issues and ensure smooth and effective continuity of care: This allows your prescriber to closely monitor how you are responding, address any side effects or concerns early, make adjustments when needed, and help avoid any gaps in care. This also keeps you on a consistent schedule, allows us to stay ahead of your prescription needs, and helps prevent last-minute issues. Spacing visits too far apart can create situations where an appointment is due but your prescriber does not have availability right away, which could delay a refill, especially if there are side effects that need to be addressed. However, for the first year of treatment, our requirement is to have at least one visit every 3 months. After the first year of treatment, visit frequency will be determined by your prescriber on a case-by-case basis based on your stability, treatment response, and ongoing needs.
We understand that telehealth has become an important and convenient part of care for many of our clients. With the updated New Jersey regulations, we have adjusted our scheduling process to make sure we continue providing safe, compliant, and uninterrupted care.
TheraCorp has been preparing for these changes and has appointment availability to help you meet any required visit schedule. We are also in-network with major insurance plans, making it easier to continue your care with us.
If you have questions about your appointment requirements or need help scheduling your next visit, our team is here to help.
Contact us today to make sure your care starts and stays on track!
(732) 561-8555
Comments